PubMed

Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells.

Spitzer MS, Wallenfels-Thilo B, Sierra A, Yoeruek E, Peters S, Henke-Fahle S, Bartz-Schmidt KU, Szurman P; Tuebingen Bevacizumab Study Group.

Br J Ophthalmol. 2006 Oct;90(10):1316-21. Epub 2006 May 24.PMID: 16723358 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells.

Spitzer MS, Yoeruek E, Sierra A, Wallenfels-Thilo B, Schraermeyer U, Spitzer B, Bartz-Schmidt KU, Szurman P.

Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1837-42. Epub 2007 Mar 9.PMID: 17347807 [PubMed - indexed for MEDLINE]Related articles

Differential toxic effect of dissolved triamcinolone and its crystalline deposits on cultured human retinal pigment epithelium (ARPE19) cells.

Szurman P, Kaczmarek R, Spitzer MS, Jaissle GB, Decker P, Grisanti S, Henke-Fahle S, Aisenbrey S, Bartz-Schmidt KU.

Exp Eye Res. 2006 Sep;83(3):584-92. Epub 2006 May 8.PMID: 16684520 [PubMed - indexed for MEDLINE]Related articles

Safety profile of bevacizumab on cultured human corneal cells.

Yoeruek E, Spitzer MS, Tatar O, Aisenbrey S, Bartz-Schmidt KU, Szurman P.

Cornea. 2007 Sep;26(8):977-82.PMID: 17721300 [PubMed - indexed for MEDLINE]Related articles

Antiproliferative effects of preservative-free triamcinolone acetonide on cultured human retinal pigment epithelial cells.

Kaczmarek R, Szurman P, Misiuk-Hojło M, Grzybowski A.

Med Sci Monit. 2009 Aug;15(8):BR227-31.PMID: 19644411 [PubMed - indexed for MEDLINE]Related articles

Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: efficiency and possible additional pathways.

Klettner A, Roider J.

Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4523-7. Epub 2008 Apr 25.PMID: 18441313 [PubMed - indexed for MEDLINE]Related articlesFree article

Choroidal endothelial cells transmigrate across the retinal pigment epithelium but do not proliferate in response to soluble vascular endothelial growth factor.

Geisen P, McColm JR, Hartnett ME.

Exp Eye Res. 2006 Apr;82(4):608-19. Epub 2005 Nov 2.PMID: 16259980 [PubMed - indexed for MEDLINE]Related articles

Antipermeability and antiproliferative effects of standard and frozen bevacizumab on choroidal endothelial cells.

Peters S, Julien S, Heiduschka P, Grisanti S, Ziemssen F, Adler M, Schraermeyer U, Bartz-Schmidt KU.

Br J Ophthalmol. 2007 Jun;91(6):827-31. Epub 2006 Dec 19.PMID: 17179166 [PubMed - indexed for MEDLINE]Related articles

Effect of anti-VEGF antibody on retinal ganglion cells in rats.

Iriyama A, Chen YN, Tamaki Y, Yanagi Y.

Br J Ophthalmol. 2007 Sep;91(9):1230-3. Epub 2007 May 2.PMID: 17475701 [PubMed - indexed for MEDLINE]Related articles

Different biocompatibility of crystalline triamcinolone deposits on retinal cells in vitro and in vivo.

Szurman P, Sierra A, Kaczmarek R, Jaissle GB, Wallenfels-Thilo B, Grisanti S, Lüke M, Bartz-Schmidt KU, Spitzer MS.

Exp Eye Res. 2007 Jul;85(1):44-53. Epub 2007 Mar 19.PMID: 17475249 [PubMed - indexed for MEDLINE]Related articles

Evaluation of in vitro effects of bevacizumab (Avastin) on retinal pigment epithelial, neurosensory retinal, and microvascular endothelial cells.

Luthra S, Narayanan R, Marques LE, Chwa M, Kim DW, Dong J, Seigel GM, Neekhra A, Gramajo AL, Brown DJ, Kenney MC, Kuppermann BD.

Retina. 2006 May-Jun;26(5):512-8.PMID: 16770256 [PubMed - indexed for MEDLINE]Related articles

[Bevacizumab is not toxic to human anterior- and posterior-segment cultured cells]

Kernt M, Welge-Lüssen U, Yu A, Neubauer AS, Kampik A.

Ophthalmologe. 2007 Nov;104(11):965-71. German. PMID: 17653724 [PubMed - indexed for MEDLINE]Related articles

In vitro evaluation of bevacizumab toxicity on a retinal ganglion cell line.

Sharma RK, Chalam KV.

Acta Ophthalmol. 2009 Sep;87(6):618-22. Epub 2009 Jun 26.PMID: 19563375 [PubMed - indexed for MEDLINE]Related articles

Bevacizumab is not toxic to retinal ganglion cells after repeated intravitreal injection.

Cheng CK, Peng PH, Tien LT, Cai YJ, Chen CF, Lee YJ.

Retina. 2009 Mar;29(3):306-12.PMID: 19060776 [PubMed - indexed for MEDLINE]Related articles

Effects of bevacizumab (Avastin) on retinal cells in organotypic culture.

Kaempf S, Johnen S, Salz AK, Weinberger A, Walter P, Thumann G.

Invest Ophthalmol Vis Sci. 2008 Jul;49(7):3164-71. Epub 2008 Mar 14.PMID: 18344448 [PubMed - indexed for MEDLINE]Related articlesFree article

Vascular endothelial growth factor reduced and connective tissue growth factor induced by triamcinolone in ARPE19 cells under oxidative stress.

Matsuda S, Gomi F, Oshima Y, Tohyama M, Tano Y.

Invest Ophthalmol Vis Sci. 2005 Mar;46(3):1062-8.PMID: 15728566 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of triamcinolone on the expression of VEGF and PEDF in human retinal pigment epithelial and human umbilical vein endothelial cells.

Tong JP, Lam DS, Chan WM, Choy KW, Chan KP, Pang CP.

Mol Vis. 2006 Dec 4;12:1490-5.PMID: 17167405 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparative effects of bevacizumab, ranibizumab and pegaptanib at intravitreal dose range on endothelial cells.

Carneiro A, Falcão M, Pirraco A, Milheiro-Oliveira P, Falcão-Reis F, Soares R.

Exp Eye Res. 2009 Mar;88(3):522-7. Epub 2008 Nov 30.PMID: 19135441 [PubMed - indexed for MEDLINE]Related articles

[Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress]

Kook D, Wolf A, Neubauer AS, Haritoglou C, Priglinger SG, Kampik A, Ulbig MW.

Ophthalmologe. 2008 Feb;105(2):158-64. German. PMID: 17653552 [PubMed - indexed for MEDLINE]Related articles

Fluocinolone inhibits VEGF expression via glucocorticoid receptor in human retinal pigment epithelial (ARPE-19) cells and TNF-alpha-induced angiogenesis in chick chorioallantoic membrane (CAM).

Ayalasomayajula SP, Ashton P, Kompella UB.

J Ocul Pharmacol Ther. 2009 Apr;25(2):97-103.PMID: 19284324 [PubMed - indexed for MEDLINE]Related articles